| 期 |
栏目 |
标题 |
文件 |
| 卷 1, 编号 2 (1999) |
Articles |
Redkoe sochetanie sinkhronnykh bilateral'nykh zlokachestvennykh opukholey molochnykh zhelez |
|
| 卷 2, 编号 2 (2000) |
Articles |
Navel'bin v kombinatsii s doksorubitsinom v terapii I linii u bol'nykh pervichno-disseminirovannym i metastaticheskim rakom molochnoy zhelezy (predvaritel'nye dannye) |
|
| 卷 2, 编号 4 (2000) |
Articles |
Klinicheskoe znachenie protivoopukholevogo preparata «Myustoforan» |
|
| 卷 3, 编号 2 (2001) |
Articles |
Novye vozmozhnosti v terapii zrelokletochnykh nekhodzhkinskikh limfom: preparat "Mabtera" - nastoyashchee i budushchee |
|
| 卷 3, 编号 1 (2001) |
Articles |
Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov) |
|
| 卷 3, 编号 4 (2001) |
Articles |
Pervichnye MALT-limfomy zheludka u bol'nykh pozhilogo vozrasta |
|
| 卷 3, 编号 3 (2001) |
Articles |
Novye vozmozhnosti endokrinnoy terapii raka molochnoy zhelezy |
|
| 卷 3, 编号 3 (2001) |
Articles |
Farmakoekonomicheskiy analiz "stoimost'-poleznost'" kak kriteriy ekonomicheskoy obosnovannosti ispol'zovaniya byudzhetnykh sredstv v onkologii |
|
| 卷 3, 编号 4 (2001) |
Articles |
Aktivatory plazminogena urokinaznogo i tkanevogo tipov i ikh ingibitor pervogo tipa pri rake pishchevoda (predvaritel'nye rezul'taty) |
|
| 卷 3, 编号 4 (2001) |
Articles |
Mabtera v terapii nekhodzhkinskikh limfom vysokoy stepeni zlokachestvennosti: skhema R-CHOP |
|
| 卷 3, 编号 4 (2001) |
Articles |
Mabtera u pozhilykh bol'nykh nekhodzhkinskimi limfomami nizkoy stepeni zlokachestvennosti: novye vozmozhnosti lecheniya |
|
| 卷 3, 编号 4 (2001) |
Articles |
Vozmozhnosti primeneniya kleksana v onkologii |
|
| 卷 4, 编号 1 (2002) |
Articles |
Novyy vek - novye vozmozhnosti khimioterapii: temodal v lechenii zlokachestvennykh opukholey |
|
| 卷 4, 编号 3 (2002) |
Articles |
Primenenie mabtery (rituksimaba) s antratsiklinosoderzhashchimi kombinatsiyami khimiopreparatov v kachestve pervoy linii lecheniya bol'nykh V-kletochnymi NKhL s neblagopriyatnym prognozom (predvaritel'nye rezul'taty) |
|
| 卷 5, 编号 1 (2003) |
Articles |
Regional'naya programma lecheniya mestno - rasprostranennogo i metastaticheskogo raka molochnoy zhelezy |
|
| 卷 5, 编号 1 (2003) |
Articles |
Organizatsionno-metodicheskie aspekty realizatsii Regional'noy programmy lecheniya mestno-rasprostranennogo i metastaticheskogo raka molochno y zhelezy s ispol'zovaniem rezhima dotsetaksel/doksorubitsin |
|
| 卷 5, 编号 2 (2003) |
Articles |
Dostizheniya sovremennoy khimioterapii |
|
| 卷 5, 编号 3 (2003) |
Articles |
Analiz sostoyaniya onkologicheskoy pomoshchi v Respublike Sakha (Yakutiya) za 1991-2001 gg |
|
| 卷 5, 编号 3 (2003) |
Articles |
Sostoyanie zabolevaemosti, smertnosti i onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh gastroenterologicheskoy lokalizatsi i v Respublike Sakha (Yakutiya) za 1991-2001 gg |
|
| 卷 5, 编号 3 (2003) |
Articles |
Analiz sostoyaniya onkoginekologicheskoy pomoshchi naseleniyu v Respublike Sakha (Yakutiya) |
|
| 卷 5, 编号 3 (2003) |
Articles |
Videotarakoskopicheskaya parasternal'naya limfodissektsiya v diagnostike raka molochnoy zhelezy |
|
| 卷 5, 编号 3 (2003) |
Articles |
Gistologicheskie i gistoimmunokhimicheskie osobennosti uveal'noy melanomy pri pervichno-mnozhestvennom porazhenii i solitarnoy uveal'noy melanome |
|
| 卷 5, 编号 4 (2003) |
Articles |
Problemy lecheniya nemelkokletochnogo raka legkogo |
|
| 卷 5, 编号 4 (2003) |
Articles |
Osnovnye problemy optimizatsii okazaniya onkologicheskoy pomoshchi naseleniyu( Yakutsk, 1992 - 2002 gg.) |
|
| 卷 6, 编号 1 (2004) |
Articles |
Regional'naya programma lecheniya bol'nykh disseminirovannym rakom yaichnika ( I I B - I V stadii ): aktual'nost', tsel', predvaritel'nye rezul'taty |
|
| 卷 6, 编号 2 (2004) |
Articles |
Rol' bisfosfonatov v lechenii raka molochnoy zhelezy |
|
| 卷 6, 编号 1 (2004) |
Articles |
Sravnitel'naya kharakteristika effektivnosti skhem CHOP i Mabtera + CHOP (R-CHOP) v lechenii bol'nykh diffuznoy krupnokletochnoy V-kletochnoy nekhodzhkinskoy limfomoy |
|
| 卷 6, 编号 4 (2004) |
Articles |
Rezul'taty vnedreniya Regional'noy programmy po optimizatsii lecheniya rasprostranennogo raka yaichnikov v rossiyskikh onkologicheskikh dispanserakh na seredinu dekabrya 2004 g |
|
| 卷 6, 编号 4 (2004) |
Articles |
Analiz lecheniya onkoginekologicheskikh opukholey v Yakutii |
|
| 卷 7, 编号 1 (2005) |
Articles |
Sotsial'no-ekonomicheskie aspekty organizatsii protivorakovoy bor'by v Respublike Sakha (Yakutiya) (1991-2001 gg.) |
|
| 卷 7, 编号 2 (2005) |
Articles |
«Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy» |
|
| 卷 7, 编号 2 (2005) |
Articles |
Zavisimost' vozniknoveniya retsidiva raka yaichnika rannikh stadiy ot prognosticheskikh faktorov |
|
| 卷 7, 编号 2 (2005) |
Articles |
Punktsionno-dreniruyushchiy metod - effektivnoe lechenie posleoperatsionnykh khirurgicheskikh oslozhneniy v torakoabdominal'noy onkologii |
|
| 卷 8, 编号 1 (2006) |
Articles |
Nekhodzhkinskie limfomy marginal'noy zony |
|
| 卷 8, 编号 1 (2006) |
Articles |
Dopolnitel'nye kliniko-laboratornye faktory prognoza pri diffuznoy krupnokletochnoy V-kletochnoy limfome |
|
| 卷 8, 编号 1 (2006) |
Articles |
Vozmozhnosti endoskopicheskoy i differentsial'noy diagnostiki ekstranodal'nykh b-kletochnykh limfom zheludka marginal'noy zony MALT-tipa |
|
| 卷 8, 编号 4 (2006) |
Articles |
Osobennosti klinicheskogo techeniya i prognoz bol'nykh nekhodzhkinskoy limfomoy s pervichnoy lokalizatsiey v yaichke |
|
| 卷 9, 编号 1 (2007) |
Articles |
Novye gorizonty immunoterapii nekhodzhkinskikh limfom iz kletok zony mantii |
|
| 卷 9, 编号 1 (2007) |
Articles |
Mesto UZT pri planirovanii lecheniya zlokachestvennykh epitelial'nykh opukholey yaichnikov |
|
| 卷 9, 编号 3 (2007) |
Articles |
Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie |
|
| 卷 9, 编号 4 (2007) |
Articles |
Rezolyutsiya ekspertnogo soveshchaniya po ispol'zovaniyu eritropoezstimuliruyushchikh preparatov (ESP) v onkologii ot 3 noyabrya 2007 g |
|
| 卷 9, 编号 3 (2007) |
Articles |
Lechenie anemii v onkologii: rol' novogo stimulyatora eritropoeza Aranesp (darbepoetin al'fa) |
|
| 卷 10, 编号 2 (2008) |
Articles |
ANAPLASTIChESKAYa KRUPNOKLETOChNAYa LIMFOMA VZROSLYKh:VLIYaNIE PROGNOSTIChESKIKh FAKTOROV NA TERAPIYu |
|
| 卷 10, 编号 2 (2008) |
Articles |
Novoe v terapii gastrointestinal'nykh stromal'nykh opukholey –ad\"yuvantnaya terapiya |
|
| 卷 10, 编号 3 (2008) |
Articles |
Ot glavnogo redaktora Uvazhaemye kollegi! |
|
| 卷 10, 编号 3 (2008) |
Articles |
Pervichnaya mediastinal'nayaV-krupnokletochnaya limfoma: diagnostika, klinicheskaya kartina i lechenie |
|
| 卷 10, 编号 3 (2008) |
Articles |
Lechenie bol'nykh diffuznoy B-krupnokletochnoy limfomoy s pervichnym porazheniem yaichka: standartnaya terapiya ± Rutiksimab |
|
| 卷 10, 编号 3 (2008) |
Articles |
Ekstranodal'nye nekhodzhkinskie limfomy s porazheniem myagkikh tkaney |
|
| 卷 10, 编号 3 (2008) |
Articles |
Znachenie Mezhdunarodnogo prognosticheskogo indeksa dlya prognoza pri nekhodzhkinskoy limfome organa zreniya |
|
| 卷 11, 编号 1 (2009) |
Articles |
Effektivnost' Taksoterav neoad\"yuvantnoy i ad\"yuvantnoy khimioterapii raka molochnoy zhelezy (Po materialam mezhdunarodnykh issledovaniy) |
|
| 卷 11, 编号 2 (2009) |
Articles |
Rol' Taksotera v lechenii metastaticheskogo raka molochnoy zhelezy |
|
| 卷 11, 编号 2 (2009) |
Articles |
Primenenie selena v onkologii |
|
| 卷 11, 编号 3 (2009) |
Articles |
Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo |
|
| 卷 12, 编号 1 (2010) |
Articles |
Bevatsizumab pri metastaticheskomi retsidiviruyushchem rake molochnoy zhelezy:metaanaliz randomizirovannykh issledovaniy |
|
| 卷 12, 编号 1 (2010) |
Articles |
Mestnorasprostranennyy i metastaticheskiygormonopozitivnyy rak molochnoy zhelezy:problemy terapii i perspektivyprimeneniya lapatiniba v kombinatsiis ingibitorami aromatazy v kachestveterapii pervoy linii |
|
| 卷 12, 编号 1 (2010) |
Articles |
Mesto fulvestranta v endokrinoterapiimetastaticheskogo raka molochnoy zhelezy |
|
| 卷 12, 编号 2 (2010) |
Articles |
Vozmozhnosti primeneniya sorafenibav neoad\"yuvantnom rezhimepri pochechno-kletochnom rake |
|
| 卷 12, 编号 2 (2010) |
Articles |
Khimioterapiya raka sheyki matki:rol' topotekana v bor'be za uvelichenievyzhivaemosti i uluchshenie kachestvazhizni patsientov |
|
| 卷 12, 编号 1 (2010) |
Articles |
Razvitie lekarstvennoy terapiiraka pochki |
|
| 卷 12, 编号 2 (2010) |
Articles |
Terapevticheskie problemypri limfome zony mantii |
|
| 卷 12, 编号 3 (2010) |
Articles |
Kapetsitabin v ad\"yuvantnoy terapiiraka molochnoy zhelezy |
|
| 卷 12, 编号 3 (2010) |
Articles |
Rol' lapatiniba v terapiimetastaticheskogo raka molochnoyzhelezy s ekspressiey gormonal'nykhretseptorov |
|
| 卷 12, 编号 3 (2010) |
Articles |
Nekhodzhkinskie limfomy kishechnika -pervichnoe ekstranodal'noe porazhenie |
|
| 卷 12, 编号 3 (2010) |
Articles |
Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh |
|
| 卷 13, 编号 2 (2011) |
Articles |
Prognoz bilateral'nykh pervichnykhnekhodzhkinskikh limfom organa zreniya |
|
| 卷 13, 编号 2 (2011) |
Articles |
Effektivnost' zatrat nabendamustin v terapii indolentnykhnekhodzhkinskikh limfom |
|
| 卷 13, 编号 2 (2011) |
Articles |
Klinicheskie rekomendatsii po profilaktikei lecheniyu toshnoty i rvoty u bol'nykh,poluchayushchikh khimio- i luchevuyuprotivoopukholevuyu terapiyu |
|
| 卷 15, 编号 1 (2013) |
Articles |
Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice |
|
| 卷 15, 编号 1 (2013) |
Articles |
CUP-syndrome: the present view of the problem (a review of literature) |
|
| 卷 15, 编号 2 (2013) |
Articles |
Prognostic value of p53 expression in patients with stage I breast cancer |
|
| 卷 15, 编号 2 (2013) |
Articles |
Toxicity of trabectedin-based combinations in the treatment of different malignant tumors |
|
| 卷 15, 编号 4 (2013) |
Articles |
Pharmacoeconomic potency assignment of targeted agents in the treatment of metastatic colorectal cancer with wild-type Kras |
|
| 卷 15, 编号 4 (2013) |
Articles |
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer |
|
| 卷 15, 编号 4 (2013) |
Articles |
Bone mineral density in patient with breast cancer |
|
| 卷 16, 编号 1 (2014) |
Articles |
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program |
|
| 卷 16, 编号 2 (2014) |
Articles |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013 |
|
| 卷 16, 编号 4 (2014) |
Articles |
Modern possibilities of HER2 positive breast cancer treatment (based on clinical trials) |
|
| 卷 16, 编号 4 (2014) |
Articles |
Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I? |
|
| 卷 17, 编号 1 (2015) |
Articles |
Breast cancer immunology: theory and prospects (review) |
|
| 卷 16, 编号 3 (2014) |
Articles |
Vulvar Langerhans cell histiocytosis: case report |
|
| 卷 17, 编号 1 (2015) |
Articles |
A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian |
|
| 卷 17, 编号 1 (2015) |
Articles |
Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience) |
|
| 卷 17, 编号 3 (2015) |
Articles |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2014 |
|
| 卷 17, 编号 3 (2015) |
Articles |
Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer |
|
| 卷 17, 编号 3 (2015) |
Articles |
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer |
|
| 卷 18, 编号 1 (2016) |
Articles |
Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy |
(Rus)
|
| 卷 18, 编号 1 (2016) |
Articles |
Insulin-like growth factors in patients with ovarian tumors (results of own research) |
(Rus)
|
| 卷 18, 编号 2 (2016) |
Articles |
Dural non-Hodgkin’s lymphomas |
(Rus)
|
| 卷 18, 编号 3 (2016) |
Articles |
The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015 |
(Rus)
|
| 卷 18, 编号 2 (2016) |
Articles |
Prognostic factors in patients with disseminated gastrointestinal stromal tumors |
(Rus)
|
| 卷 18, 编号 3 (2016) |
Articles |
Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer |
(Rus)
|
| 卷 19, 编号 1 (2017) |
Articles |
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer |
(Rus)
|
| 卷 19, 编号 2 (2017) |
Articles |
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy |
(Rus)
|
| 卷 19, 编号 4 (2017) |
Articles |
Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0 |
(Rus)
|
| 卷 19, 编号 3 (2017) |
Articles |
Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer |
(Rus)
|
| 卷 20, 编号 1 (2018) |
Articles |
Taxanes induced peripheral neuropathy: mechanism of development and pharmacogenetic factors |
(Rus)
|
| 卷 13, 编号 1 (2011) |
Articles |
Retsidivy follikulyarnoy limfomy: problemy i puti resheniya |
|
| 卷 13, 编号 3 (2011) |
Articles |
Allel'nye varianty v genakh BRCA1,BRCA2, TP53, assotsiirovannyes razvitiem raka molochnoy zhelezy |
|
| 卷 13, 编号 3 (2011) |
Articles |
Osteopontin, CD55:prognosticheskie faktory riskapri rake molochnoy zhelezy |
|
| 卷 13, 编号 4 (2011) |
Articles |
Biosimilyary: novye vozmozhnostisovremennoy lekarstvennoy terapiiopukholey |
|
| 卷 14, 编号 1 (2012) |
Articles |
Rakovye registry:vchera, segodnya, zavtra |
|
| 卷 13, 编号 4 (2011) |
Articles |
Pervichnye nekhodzhkinskielimfomy kostey |
|
| 卷 14, 编号 1 (2012) |
Articles |
Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie) |
|
| 卷 14, 编号 2 (2012) |
Articles |
Rakovye registry: vchera, segodnya, zavtra. Chast' 2 |
|
| 卷 14, 编号 1 (2012) |
Articles |
Nasledstvennyy rak yaichnika(literaturnyy obzor) |
|
| 卷 14, 编号 3 (2012) |
Articles |
Vmeste k novym dostizheniyam v lechenii limfoproliferativnykh zabolevaniyKlinicheskiy limforum, Irkutsk, 23-24 avgusta 2012 g., i novye plany na 2012- 2013 gg. |
|
| 卷 14, 编号 3 (2012) |
Articles |
Rakovye registry v mire. Chast' 3. PHAROS - Gollandskiy populyatsionnyy registr onkogematologicheskikh bol'nykh |
|
| 卷 14, 编号 2 (2012) |
Articles |
Tretichnyy pokazatel' Glisona kak faktor prognoza retsidiva raka predstatel'noy zhelezy |
|
| 卷 14, 编号 3 (2012) |
Articles |
Novyy vzglyad na biologicheskie osobennosti pervichnoy ekstranodal'noy diffuznoy V-krupnokletochnoy limfomy |
|
| 卷 14, 编号 4 (2012) |
Articles |
Rekomendatsiipo khronicheskomu limfoleykozu |
|
| 卷 14, 编号 4 (2012) |
Articles |
Rakovye registry. Chast' 4. Rossiyskiy registr «Limfoproliferativnye zabolevaniya» |
|
| 卷 14, 编号 4 (2012) |
Articles |
Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy |
|
| 卷 14, 编号 4 (2012) |
Articles |
Znachenie ul'trachuvstvitel'nogo metoda kolichestvennogo opredeleniya prostaticheskogo spetsificheskogo antigena v diagnostike retsidiva raka predstatel'noy zhelezy |
|
| 卷 20, 编号 3 (2018) |
Articles |
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer |
(Rus)
|
| 卷 20, 编号 4 (2018) |
Articles |
Quality control of immunohistochemical analyzes in Russia: yesterday, today, tomorrow |
(Rus)
|
| 卷 20, 编号 4 (2018) |
Articles |
Bendamustine in the treatment of B-cell non-Hodgkin lymphoma |
(Rus)
|
